Amee Chetan Shah's most recent trade in Senores Pharmaceuticals Ltd. was a Acquisition of 300 Equity Shares done at an average price of Rs. 654.0 . Disclosure was reported to the exchange on Aug. 1, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Amee Chetan Shah in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals | Amee Chetan Shah | Directors Immediate Relative | Acquisition | 01 Aug 2025 | 300 | 500 (0%) | 0.00% | 654.0 | 196,210 | 28 Jul 2025 28 Jul 2025 |
Insider Trading | Equity Shares | Market Purchase |